Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study.
Kim TS, Rha SW, Kim SY, Park DG, Sung KC, Yoon MH, Kim KH, Lee HC, Kim WS, Kim YJ, Ahn JC, Rhee MY, Cha DH, Yoo BS, Park SH, Yoo KD, Jeon DW, Yoon YW, Cho SK, Oh YS. Kim TS, et al. Among authors: park sh, park dg. Clin Ther. 2019 Apr;41(4):728-741. doi: 10.1016/j.clinthera.2019.02.013. Epub 2019 Mar 21. Clin Ther. 2019. PMID: 30904178 Free article. Clinical Trial.
A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia.
Lee HY, Kim SY, Choi KJ, Yoo BS, Cha DH, Jung HO, Ryu DR, Choi JH, Lee KJ, Park TH, Oh JH, Kim SM, Choi JY, Kim KH, Shim J, Kim WS, Choi SW, Park DG, Song PS, Hong TJ, Rhee MY, Rha SW, Park SW. Lee HY, et al. Among authors: park th, park sw, park dg. Clin Ther. 2017 Dec;39(12):2366-2379. doi: 10.1016/j.clinthera.2017.10.013. Epub 2017 Nov 14. Clin Ther. 2017. PMID: 29150250 Free article. Clinical Trial.
Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial.
Choi DJ, Park CS, Park JJ, Lee HY, Kang SM, Yoo BS, Jeon ES, Hong SK, Shin JH, Kim MA, Park DG, Kim EJ, Hong SJ, Kim SY, Kim JJ. Choi DJ, et al. Among authors: park cs, park jj, park dg. Trials. 2018 Feb 13;19(1):103. doi: 10.1186/s13063-018-2470-5. Trials. 2018. PMID: 29433525 Free PMC article.
BioMatrix versus Orsiro biodegradable polymer stents in all-comer patients with coronary artery disease: the multicentre, randomised BIODEGRADE trial.
Yoon CH, Choi YJ, Park JJ, Kang SH, Kim SH, Suh JW, Cho YS, Youn TJ, Kim MK, Cha KS, Lee SH, Hong BK, Rha SW, Kang WC, Lee JH, Kim SH, Chae IH; Collaborators. Yoon CH, et al. EuroIntervention. 2021 Apr 20;16(17):1404-1412. doi: 10.4244/EIJ-D-20-00185. EuroIntervention. 2021. PMID: 32958459 Free PMC article. Clinical Trial.
Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): a Prospective Randomized, Open-Label, Multicenter Study.
Park CS, Park JJ, Lee HY, Kang SM, Yoo BS, Jeon ES, Hong SK, Shin JH, Kim MA, Park DG, Kim EJ, Hong SJ, Kim SY, Kim JJ, Choi DJ. Park CS, et al. Among authors: park jj, park dg. Cardiovasc Drugs Ther. 2023 Jun;37(3):529-537. doi: 10.1007/s10557-021-07238-3. Epub 2022 Jan 23. Cardiovasc Drugs Ther. 2023. PMID: 35066737 Clinical Trial.
Correction: Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial.
Choi DJ, Park CS, Park JJ, Lee HY, Kang SM, Yoo BS, Jeon ES, Hong SK, Shin JH, Kim MA, Park DG, Kim EJ, Hong SJ, Kim SY, Kim JJ. Choi DJ, et al. Among authors: park cs, park jj, park dg. Trials. 2022 Jul 25;23(1):594. doi: 10.1186/s13063-022-06559-4. Trials. 2022. PMID: 35879804 Free PMC article. No abstract available.
A multicenter, eight-week treatment, single-step titration, open-label study assessing the percentage of Korean dyslipidemic patients achieving LDL cholesterol target with atorvastatin starting doses of 10 mg, 20 mg and 40 mg.
Lee CW, Baek SH, Hong TJ, Choi YJ, Kim YJ, Ahn TH, Ihm SH, Bae JH, Hong SJ, Kim DI, Ahn YK, Hur SH, Park DG, Choi DJ, Lee SU, Kim BS, Ryu KH, Jang YS, Lee SH, Seung KB, Kim HS. Lee CW, et al. Among authors: park dg. Cardiovasc Drugs Ther. 2010 Apr;24(2):181-8. doi: 10.1007/s10557-010-6225-0. Cardiovasc Drugs Ther. 2010. PMID: 20383571 Clinical Trial.
2023 Korean Society of Echocardiography position paper for the diagnosis and management of valvular heart disease, part II: mitral and tricuspid valve disease.
Shim CY, Kim EK, Cho DH, Park JB, Seo JS, Son JW, Kim IC, Lee SH, Heo R, Lee HJ, Lee S, Sun BJ, Yoon SJ, Lee SH, Kim HY, Kim HM, Park JH, Hong GR, Jung HO, Kim YJ, Kim KH, Kang DH, Ha JW, Kim H; Korean Valve Survey Investigators. Shim CY, et al. J Cardiovasc Imaging. 2024 Jun 25;32(1):10. doi: 10.1186/s44348-024-00021-6. J Cardiovasc Imaging. 2024. PMID: 38951920 Free PMC article. Review.
137 results